Obesity is associated with increased production of RANKL by osteoblasts as well as elevated levels of the RANKL/OPG ratio, where OPG is an antagonist of RANKL activation (Xu et al., 2013). Here, TNFSF11 is linked to obesity due to melanocortin 4 receptor deficiency.